GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Sales | 88 | 220 | 120 | 1 | 1 |
| Cost of Goods | 69 | 61 | 32 | N/A | 1 |
| Gross Profit | 19 | 159 | 88 | 1 | N/A |
| Operating Expenses | 435 | 957 | 1,470 | 1,031 | 398 |
| Operating Income | -347 | -738 | -1,350 | -1,030 | -396 |
| Interest Expense | 531 | 348 | 65 | 1,166 | 74 |
| Other Income | 1,346 | 325 | 15 | -199 | -145 |
| Pre-tax Income | 468 | -761 | -1,400 | -2,395 | -615 |
| Net Income Continuous | 468 | -761 | -1,400 | -2,395 | -615 |
| Net Income | $468 | $-761 | $-1,400 | $-2,395 | $-615 |
| EPS Basic Total Ops | 0.00 | N/A | 0.00 | -0.01 | 0.00 |
| EPS Basic Continuous Ops | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
| EPS Diluted Total Ops | 0.00 | N/A | 0.00 | -0.01 | 0.00 |
| EPS Diluted Continuous Ops | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
| EBITDA(a) | $-53 | $-744 | $-1,349 | $-1,013 | $-365 |